SAM #75N98026Q00866

Development and Validation of Transferrin Receptor – Sole Source to Creative Biolabs

• The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, is seeking specialized services for the development and validation of a Transferrin Receptor.
• Creative Biolabs is identified as the sole source provider due to their unique capability to deliver a customized humanized antibody library screening service tailored to NHGRI's technical and continuity needs.
• The scope includes:
  • Development and validation of a Transferrin Receptor using a humanized antibody library
  • Transfer of resulting intellectual property to NIH under a Materials Transfer Agreement
• The opportunity is open for small businesses to submit capability statements, but the anticipated awardee is Creative Biolabs.
• Notable requirements:
  • Customization of antibody library screening
  • Strict transfer of intellectual property rights to the government
• No specific product part numbers or quantities are listed, as this is a specialized R&D service engagement.

Description

See attach Notice of Intent

(75N98026Q00866)

View original listing